Augurex Life Sciences Corp. news
Do you have a patient with Systemic Lupus Erythematosus (SLE) that you suspect may also have Sjögren’s Syndrome (SS)?
With shared clinical and serological features, overlapping SS with SLE is a comorbidity that is often challenging to identify to promptly assist clinical management. This may also lead to misdiagnoses of other connective tissue disorders.
New data on 14-3-3η (eta) enhances the detection rates of patients with seconda
Ms. Dakers began her career in Life Sciences at the University of British Columbia, managing technology transfer for the University Industry Liaison Office (UILO) where she was involved in the creation and spin-off of more than a dozen start-up high-tech and biotech companies. She then went on to co-found NeuroMed Technologies Inc., a private biotechnology company developing drugs for pain, anxiety, epilepsy, and cardiovascular disease where she raised $70M in venture funding. She
USPTO Awards Patent for Citrullinated 14-3-3: Expanding Augurex’s Portfolio in the Diagnosis of Rheumatoid Arthritis (RA)
On November 20th, 2018 the US Patent and Trademark Office (USPTO) awarded patent number 10,132,806 entitled “Antigens Derived From Citrullinated 14-3-3 And Uses Thereof In The Diagnosis of Rheumatoid Arthritis.” Citrullinated 14-3-3η auto-antibodies are express
Augurex and Quidel are pleased to announce the launch of the JOINTstat® 14-3-3η RUO (research use only) ELISA. This new distribution arrangement will get 14-3-3η testing into the hands of more investigators worldwide, including key opinion leaders and pharmaceutical companies, to advance and grow the body of data for this novel joint damage biomarker in autoimmune diseases.
There is increasing international momentum to investigate the role of 14-3-3η in various autoimm
At the annual European congress of rheumatology meeting, The European League Against Rheumatism (EULAR), taking place in Amsterdam on June 13th-16th, leading investigators from United States, Israel, and Egypt will present new data on the 14-3-3η blood test. Several of these studies grow the body of evidence of 14-3-3η’s key role as an early diagnostic test th
Did you miss the Digital Technology Supercluster Member Spotlight on Augurex?
Read how Augurex will be working alongside Supercluster members like Telus Health, Providence Health Care, Microsoft and